$Aeglea BioTherapeutics, Inc.(AGLE)$ 8-K - Current report Filed: 2018-04-19 AccNo: 0001193125-18-122633 Size: 271 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接